These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21416607)

  • 1. Synthesis and antitumoral activity of gelatin/polyoxometalate hybrid nanoparticles.
    Guo R; Cheng Y; Ding D; Li X; Zhang L; Jiang X; Liu B
    Macromol Biosci; 2011 Jun; 11(6):839-47. PubMed ID: 21416607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
    Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X
    J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
    Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
    Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors.
    Ding D; Zhu Z; Liu Q; Wang J; Hu Y; Jiang X; Liu B
    Eur J Pharm Biopharm; 2011 Sep; 79(1):142-9. PubMed ID: 21272637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-circulating poly(ethylene glycol)-grafted gelatin nanoparticles customized for intracellular delivery of noscapine: preparation, in-vitro characterization, structure elucidation, pharmacokinetics, and cytotoxicity analyses.
    Madan J; Dhiman N; Sardana S; Aneja R; Chandra R; Katyal A
    Anticancer Drugs; 2011 Jul; 22(6):543-55. PubMed ID: 21471809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characterization, and induction of cell apoptosis of cocoa procyanidins-gelatin-chitosan nanoparticles.
    Zou T; Percival SS; Cheng Q; Li Z; Rowe CA; Gu L
    Eur J Pharm Biopharm; 2012 Sep; 82(1):36-42. PubMed ID: 22641023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis.
    Saraogi GK; Sharma B; Joshi B; Gupta P; Gupta UD; Jain NK; Agrawal GP
    J Drug Target; 2011 Apr; 19(3):219-27. PubMed ID: 20540651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
    Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
    Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
    Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
    Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human gelatin nanoparticles as a protein drug carrier.
    Won YW; Kim YH
    J Control Release; 2008 Apr; 127(2):154-61. PubMed ID: 18329122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and optimization of gelatin nanoparticles using the miniemulsion process.
    Ethirajan A; Schoeller K; Musyanovych A; Ziener U; Landfester K
    Biomacromolecules; 2008 Sep; 9(9):2383-9. PubMed ID: 18666795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folin-Ciocalteu Assay Inspired Polyoxometalate Nanoclusters as a Renal Clearable Agent for Non-Inflammatory Photothermal Cancer Therapy.
    Zhou J; Zhao W; Miao Z; Wang J; Ma Y; Wu H; Sun T; Qian H; Zha Z
    ACS Nano; 2020 Feb; 14(2):2126-2136. PubMed ID: 32027121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin.
    Li L; Gao FP; Tang HB; Bai YG; Li RF; Li XM; Liu LR; Wang YS; Zhang QQ
    Nanotechnology; 2010 Jul; 21(26):265601. PubMed ID: 20522924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of polyoxometalates loaded starch nanocomplex and its antitumoral activity.
    Zhai F; Li D; Zhang C; Wang X; Li R
    Eur J Med Chem; 2008 Sep; 43(9):1911-7. PubMed ID: 18440097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of magnetic gelatin nanoparticles and investigating the possible use as chemotherapeutic agent.
    Yılmaz H; Sanlıer SH
    Artif Cells Nanomed Biotechnol; 2013 Apr; 41(2):69-77. PubMed ID: 23305120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
    He M; Zhao Z; Yin L; Tang C; Yin C
    Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ surface modification of molybdenum-doped organic-inorganic hybrid TiO2 nanoparticles under hydrothermal conditions and treatment of pharmaceutical effluent.
    Shahmoradi B; Ibrahim IA; Sakamoto N; Ananda S; Row TN; Soga K; Byrappa K; Parsons S; Shimizu Y
    Environ Technol; 2010 Oct; 31(11):1213-20. PubMed ID: 21046951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy.
    Zhang HZ; Gao FP; Liu LR; Li XM; Zhou ZM; Yang XD; Zhang QQ
    Colloids Surf B Biointerfaces; 2009 Jun; 71(1):19-26. PubMed ID: 19186037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells.
    Azarmi S; Huang Y; Chen H; McQuarrie S; Abrams D; Roa W; Finlay WH; Miller GG; Löbenberg R
    J Pharm Pharm Sci; 2006; 9(1):124-32. PubMed ID: 16849014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.